Potential New Drug To Treat the Hallucinations and Delusions of Dementia Awaits FDA Approval

Being Patient spoke with Dr. Erin Foff, executive director at ACADIA Pharmaceuticals and Chris Schwilk, who lives with Lewy body dementia, about navigating the delusions and hallucinations of dementia.

We rely on donations to bring you the latest research on dementia and brain health and to support our amazing team of independent journalists. Please consider donating to support of our mission of giving people impacted by dementia a better resource and connection to experts at the forefront of research. Our audience has grown so rapidly; we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient's editorial costs.
https://beingpatient.nationbuilder.com/

---------------------------------------------------------------------------------------------------------------
Stay connected on social media:
To catch our Brain Talks live, join our Facebook page:
https://www.facebook.com/beingpatient...

To learn more about us, follow us on Instagram:
@beingpatientvoices

For the latest news on dementia research and lifestyle tips, visit our site:
https://www.beingpatient.com/

Видео Potential New Drug To Treat the Hallucinations and Delusions of Dementia Awaits FDA Approval канала Being Patient Alzheimer's